Human papillomaviruses (HPV) are double stranded DNA viruses causative in a host of human diseases 17 including several cancers. Following infection two viral proteins, E1 and E2, activate viral replication in 18 association with cellular factors, and stimulate the DNA damage response (DDR) during the replication 19 process. E1-E2 uses homologous replication (HR) to facilitate DNA replication, but an understanding of 20 host factors involved in this process remains incomplete. Previously we demonstrated that the class III 21 deacetylase SIRT1, which can regulate HR, is recruited to E1-E2 replicating DNA and regulates the level 22 of replication. Here we demonstrate that SIRT1 promotes the fidelity of E1-E2 replication and that the 23 absence of SIRT1 results in reduced recruitment of the DNA repair protein Werner helicase (WRN) to E1-24 E2 replicating DNA. CRISPR/Cas9 editing demonstrates that WRN, like SIRT1, regulates the quantity and 25 fidelity of E1-E2 replication. This is the first report of WRN regulation of E1-E2 DNA replication, or a role 26 for WRN in the HPV life cycle. In the absence of SIRT1 there is an increased acetylation and stability of 27 WRN, but a reduced ability to interact with E1-E2 replicating DNA. We present a model in which E1-E2 28 replication turns on the DDR stimulating SIRT1 deacetylation of WRN. This deacetylation promotes WRN 29 interaction with E1-E2 replicating DNA to control the quantity and fidelity of replication. As well as 30 offering a crucial insight into HPV replication control, this system offers a unique model for investigating 31 the link between SIRT1 and WRN in controlling replication in mammalian cells. 32 Importance 33
Introduction 45
Human papillomaviruses are causative agents in human diseases ranging from genital warts to ano-genital 46 and oropharyngeal cancers (1) . HPV16 is causative in around 50% of cervical cancers and 90% of HPV 47 positive oropharyngeal (HPV+OPC) cancers (1, 2) . HPV are thought to infect stem cells in the basal layer 48 of the epithelium (3), and following infection the ~8kbp circular viral DNA is delivered to the nucleus 49 where cellular factors activate viral transcription (4). This results in expression of the viral genes including 50 the oncogenes E6 and E7. E7 binds to Rb and other pocket proteins and disrupts the control of E2F 51 transcription factors, while E6 binds to and mediates the degradation of p53 (5); the overall result is to 52 promote proliferation of the infected cell. This ultimately results in differentiation that is required for viral 53 production in the upper layers of the differentiated epithelium (3, 6) . In cancer, the infected cell fails to 54 fully differentiate and continues to proliferate resulting in the accumulation of genetic damage promoting 55 cell transformation and progression to tumorigenesis. 56 HPV encodes two proteins, E1 and E2, that are required to replicate the viral genome in conjunction with 57 host factors (7) (8) (9) (10) (11) (12) (13) . The E2 protein forms homodimers and binds to 12bp palindromic sequences 58 surrounding the A/T rich origin of replication (14) . Via a protein-protein interaction in the amino terminal 59 domain of E2 the E1 helicase is recruited to the viral genome; E1 then forms a di-hexameric helicase and 60 interacts with cellular polymerases to initiate replication of the viral genome (15). Following infection, the 61 virus establishes itself at around 20-50 copies per cell. During differentiation of the infected cells there is a 62 maintenance phase of DNA replication that keeps the viral genome copy number at 20-50. In the 63 differentiated layer of the epithelium there is an amplification phase of viral replication where the viral 64 genome copy number increases to around 1000. The L1 and L2 structural proteins are then expressed and 65 viral particles are formed that egress from the upper layers of the epithelium (3). A full understanding of 66 the host proteins that regulate viral replication at all stages of the viral life cycle remains to be elucidated. 67
We identified the DNA damage-repair and replication protein TopBP1 as a cellular partner protein for 68 HPV16 E2 and demonstrated that this interaction is involved in E1-E2 replication and the viral life cycle 69 (11) (12) (13) 16) . TopBP1 is an essential gene (17) due to its role in a host of nucleic acid metabolism processes 70 that includes DNA damage recognition, signaling and repair (18) (19) (20) (21) (22) as well as DNA replication initiation 71 (16, (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) and regulation of transcription (34) (35) (36) (37) . To expand our understanding of cellular proteins 72 regulating E1-E2 DNA replication we investigated the role of known TopBP1 interactors in this process. 73
The class III deacetylase SIRT1 regulates TopBP1 function following replication and metabolic stress via 74 regulation of TopBP1 acetylation status (38, 39) . SIRT1 can also regulate the acetylation status of other 75 proteins involved in DNA replication initiation (40), therefore we postulated that SIRT1 may be able to 76 regulate E1-E2 DNA replication. We demonstrated that SIRT1 interacts with both E1 and E2 and is 77 recruited to E1-E2 replicating DNA and that CRISPR/Cas9 editing of SIRT1 resulted in elevated E1-E2 78 replication, perhaps via increased acetylation of E2 (41). SIRT1 has been shown to play a similar role in 79 mammalian DNA replication (42); phosphorylation of SIRT1 on threonine 530 promotes SIRT1 association 80 with replication origins and facilitates replication fork elongation and is required to maintain genome 81 integrity following replication stress. 82 E1-E2 DNA replication activates the DNA damage response (DDR) (43-48) and recruits a variety of 83 cellular factors required for homologous recombination (HR) to the viral genome (11, 12, 47, 49, 50) ; it has 84 been proposed that E1-E2 DNA replication proceeds via HR in the presence of an active DDR (51). The 85 reason the virus activates the DDR is related to the mode of E1-E2 replication where initiation is not 86 restricted to only once per cell cycle; re-initiation of genomes already undergoing replication would result 87 in torsional stress and potentially clashes of DNA replication forks that would activate the DDR (52). 88
Exploiting HR to maintain the fidelity of E1-E2 replication would therefore promote generation of 89 successful viral progeny. The E1-E2 interacting factor SIRT1 (41) plays a role in HR. NBS1, a member of 90 the MRN complex, is a SIRT1 substrate and deacetylation of NBS1 by SIRT1 is required for ATM 91 phosphorylation of NBS1 promoting the formation of the MRN complex (53). This MRN complex is 92 required for initiating DNA resection at damaged DNA sites in order to promote HR (25, 54) . Recruitment 93 of MRN components are required for efficient HPV DNA replication (47, 49, 50) . SIRT1 increases global 94 HR function (55), although precisely how SIRT1 does this is not known. SIRT1 is required for the 95 successful amplification of HPV31 during epithelial cell differentiation and can complex with the viral 96 genome during this process (56). Another DDR protein regulated by SIRT1 is the Werner helicase (WRN). 97
Deacetylation by SIRT1 regulates WRN stability and promotes its role in HR (57-60). WRN is unique in 98 encoding both a 3' to 5' exonuclease and 3' to 5' helicase activity and has a role in promoting genomic 99 stability; notably, Werner syndrome patients have an increased frequency of cancer incidence (61-64). 100 WRN is also involved in regulating telomere ends during replication (65), as can SIRT1 (55), further linking 101 these two proteins. 102
Here we report that E1-E2 DNA replication in the absence of SIRT1 has an increased mutation frequency 103 when compared with wild type SIRT1 cells. In the absence of SIRT1 there is an enhanced acetylation of 104 WRN and this acetylated WRN has a reduced recruitment to the E1-E2 replicating DNA. CRISPR/Cas9 105 removal of WRN results in elevated levels of E1-E2 replication and an increased mutation frequency; an 106 identical phenotype to that observed in the absence of SIRT1. Overall these results suggest that E1-E2 107 replication stimulates a DDR activating the deacetylation enzyme function of SIRT1 which then 108 deacetylates WRN and promotes the interaction of this repair protein with E1-E2 replicating DNA. The 109 recruitment of WRN controls both the levels and fidelity of E1-E2 DNA replication. We propose that this 110 SIRT1-WRN interaction also plays an important role in host DNA replication and that E1-E2 replication 111
can serve as a model to dissect this process in mammalian cells. Previously we demonstrated that SIRT1 is a member of the HPV16 E1-E2 DNA replication complex, 119 deacetylates and destabilizes E2, and controls the levels of replication (41). To do this we used 120 CRISPR/Cas9 edited cells ( Fig. 1a ). Given the role of SIRT1 in regulation of the DDR and HR we 121 investigated whether SIRT1 was involved in regulating the fidelity of E1-E2 replication. To monitor E1-122 E2 replication fidelity we employed our assay in which E1-E2 replicate a HPV16 origin containing plasmid 123 that includes the lacz gene. A description of this assay is given in materials and methods and in Fig. 1b ; we 124 have previously used this assay to investigate E1-E2 DNA replication (48, 66) . It has demonstrated that 125 HPV16 origin plasmid (pOri) in wild type C33a cells equaling 1. The controls for this experiment are 141 presented in Figs. S1b and S1c; Fig was not due to transfection efficiency, we carried out ChIP assays for E1 and E2 in C33a wild type and 145
C33a SIRT1 -/-Clone 1 cells (Fig. 1e ). The control for this figure is provided in Fig S1d. There is no 146 difference in the levels of E1 binding to the replicating DNA between the two cell types while there is an 147 increase in the E2 levels, perhaps due to the elevated levels of E2 in the absence of SIRT1 (41). This is the 148 first report of WRN being involved in E1-E2 DNA replication; WRN is a known substrate of SIRT1 (57, 149 60, 68) and a DDR protein (61, 62, 64, 68) . The levels of WRN in the absence of SIRT1 are elevated in 150
C33a cells (Figs. 1f and 1g), therefore the reduction of WRN recruitment to E1-E2 replicating DNA in the 151 absence of SIRT1 is not due to a reduction in the overall levels of the WRN protein present in C33a cells 152 in the absence of SIRT1. Moreover, this was not due to a decrease in WRN RNA levels ( Fig S1e) , therefore 153 SIRT1 regulates the expression of WRN post-transcriptionally. 154
WRN regulates the levels and fidelity of E1-E2 DNA replication. 155
To determine whether WRN could directly regulate E1-E2 replication, C33a WRN knock out cell lines 156 were generated using CRISPR/Cas9 targeting ( Fig. 2a ). The clones were sequenced to confirm disruption 157 of the WRN locus ( Fig. S2a ). E1-E2 DNA replication assays were carried out in C33a, C33a-WRN-1 and 158
C33a-WRN-2 cells and the results expressed relative to the levels in C33a wild type cells equaling 1 (Fig.  159 2b). The control for this replication assay ( Fig. S2b ) demonstrates a large increase in signal when the E1-160 E2 proteins are both expressed in C33a wild type cells versus control samples that do not express the viral 161 proteins together. In these assays neither E1 nor E2 can stimulate replication by themselves (69). WRN 162 over expression from a FLAG-tagged expression plasmid significantly repressed replication in C33a cells 163 (compare lane 2 with 1, Fig. 2b ) while knock out of WRN resulted in a significant increase in E1-E2 DNA 164 replication in both C33a WRN CRISPR clones (compare lanes 3 and 5 with lane 1). Co-expression of 165 FLAG-WRN in the CRISPR knock out cells represses E1-E2 replication (compare lanes 4 with 3 and 6 166 with 5) to levels observed in C33a wild type cells (compare lanes 4 and 6 with lane 2). The levels of the 167 E1-E2 proteins are not altered by the absence of WRN (Fig. 2c ). The result with one of the WRN CRISPR 168 knock out clones is shown but similar results were confirmed with an additional clone (data not shown). 169
These results demonstrate that WRN can regulate the levels of E1-E2 DNA replication and that this is not 170 due to an alteration in the levels of the viral replication factors. 171 WRN is a DNA repair protein involved in several aspects of preserving stalled and damaged DNA 172 replication forks promoting their repair and high-fidelity DNA replication (61-64). We again used our 173 mutagenesis assay ( Fig. 1b) to investigate whether the absence of WRN promoted mutagenic E1-E2 DNA 174 replication ( Fig. 2d ). In two independent C33a CRISPR WRN clones there was a significant increase in the 175 mutation frequency detected (compare lanes 2 and 3 with lane 1). Restoration of WRN expression during 176 E1-E2 DNA replication in the WRN CRISPR knock out cells largely restored E1-E2 DNA replication 177 fidelity ( Fig. S2c) . 178
These results demonstrate that WRN can regulate both the levels and the fidelity of E1-E2 DNA replication. 179
The restoration of WRN activity via co-transfected plasmids restored the replication levels to those in wild 180 type C33a cells, and rescued the fidelity of replication in these cells. This restoration of function by addition 181 of the wild type WRN to the CRISPR knock out cells demonstrates that the effects of WRN knock out on 182 replication in the CRISPR/Cas9 targeted cells are not due to off target effects. 183
The results in Figure 2 demonstrate that WRN knock out has a similar phenotype to that of SIRT1 knock 184 out; both presenting the phenotype of an elevation of E1-E2 DNA replication that is mutagenic in nature. 185
Moreover, Figure 1 demonstrates that there is a lack of recruitment of WRN to E1-E2 replicating DNA in 186 the absence of SIRT1 even though there are elevated levels of WRN with this absence of SIRT1. Since 187 SIRT1 regulates WRN acetylation and stability we next investigated whether control of WRN acetylation 188 by SIRT1 is the mechanism used by SIRT1 to control WRN recruitment to the E1-E2 replicating DNA in 189 C33a cells. 190
SIRT1 controls the acetylation status and stability of WRN during E1-E2 DNA replication 191
The ability of SIRT1 to deacetylate WRN was investigated in C33a cells ( Fig. 3a ). C33a SIRT1 -/-Clone 192 1 cells (41) lower panel). These results confirm that WRN is a SIRT1 substrate in C33a cells. They also suggest that 201 the SIRT1 mutant H363Y retains some deacetylation activity. The experiment shown in Fig. 3a was 202 repeated and the acetylation status of the proteins quantitated ( Fig S3a) . 203
The absence of SIRT1 increases the levels of endogenous WRN in C33a cells (Figs. 1f & 1g) . We next 204 wanted to determine if this was also the case when E1 and E2 are expressed. This was investigated by co-205 transfecting a FLAG-WRN expression vector with the viral replication factors and measuring expression 206 levels using western blotting (upper panel, Fig. 3b ). Strikingly, the presence of the E1-E2 DNA replication 207 complex reduced the levels of the WRN protein (compare the FLAG-WRN levels in lane 2 with lane 3); 208 however, this reduction in WRN is not as pronounced in the absence of SIRT1 (compare the level of FLAG-209 WRN in lanes 6 and 9 with that in lane 3). The quantification is shown in Fig. 3c . The levels of WRN 210 acetylation were also determined (lower panel, Fig. 3b ). In wild type C33a cells there is no acetylated 211 FLAG-WRN in the presence of the E1-E2 replication complex (compare lane 3 with lane 2). Since SIRT1 212 is recruited to the E1-E2 replication complex this proximity may enable more efficient deacetylation of 213 FLAG-WRN (41). In the absence of SIRT1 there is a detectable level of acetylated WRN in the presence 214 of the E1-E2 replication complex (lanes 6 and 9). The levels of the acetylated FLAG-WRN in the absence 215 of SIRT1 are reflective of the overall levels of FLAG-WRN in these cells, regardless of the presence of the 216 E1-E2 replication complex (compare the acetylated lysine IP bands with the levels of FLAG-WRN in Fig.  217 3b). Quantification of the acetylated lysine IP blots demonstrates a significant difference between the 218 acetylation status of FLAG-WRN in the presence and absence of SIRT1 (Fig. 3d ). Previous studies have 219 demonstrated that acetylated WRN has a reduced ability to bind DNA, perhaps due to the increased negative 220 charge due to the acetyl groups. Therefore, we predicted that in the absence of SIRT1 the increased 221 acetylation of WRN would prevent interaction of the WRN protein with E1-E2 replicating DNA. We tested 222 this using ChIP assays for FLAG-WRN and demonstrate that this is indeed the case; in the absence of 223 SIRT1 there is a reduced recruitment of FLAG-WRN to the E1-E2 replicating DNA (Fig 3e, DNA. It is noticeable that in the presence of the E1-E2 replication proteins there is a reduction in the levels 229 of FLAG-WRN in wild type C33a cells (Fig. 3b ). E1 contributes to the reduction of WRN levels observed 230 with the E1-E2 replication complex ( Fig. 4a& b) . There is an elevated level of E2 in the presence of E1 due 231 to enhanced stability, as we have previously reported (75). Co-immunoprecipitation experiments 232 demonstrate that FLAG-WRN and E1 exist in the same cellular complex ( Fig. 4c ), while E2 does not (Figs. 233 4a and 4b). As E1 can activate the DDR by itself and results in reduced levels of FLAG-WRN we next 234 tested whether E1 regulates the stability of FLAG-WRN. Cycloheximde (CHX) chase experiments 235 demonstrated that FLAG-WRN is stable in both C33a cells and also in C33a SIRT1 -/-Clone 1 cells (Figs. 236 4d&e, respectively). However, in the presence of the E1-E2 replication complex FLAG-WRN is 237 destabilized in wild type C33a cells ( Fig. 4f ). However, in the absence of SIRT1, FLAG-WRN is stabilized 238 ( Fig. 4g ) and E2 is also stabilized in the C33a SIRT1 -/-Clone 1 cells, as previously reported (41). The 239 levels of WRN expression were quantified and summaries are shown in Figs. S4a-d. The E1 protein retained 240 the ability to complex with FLAG-WRN in the absence of SIRT1 (Fig. S4e) . 241
The results suggest that the activation of the DDR by E1 (as we have and others have demonstrated 242 previously) stimulates SIRT1 to deacetylate WRN. This deacetylation contributes to the destabilization of 243 the WRN protein when the DDR is activated and previous studies have demonstrated that activation of the 244 DDR results in promotion of WRN degradation (76). Acetylation of WRN prevents ubiquitination and 245 therefore inhibits its degradation via the proteasome (57) (76). The E2 protein was stabilized by the addition of MG132 and we have demonstrated previously that 251 the turnover of this protein is regulated via the proteasome (77). 252
To date the results have depended upon our model systems which involve over expression of the E1 and 253 E2 proteins. We next wanted to determine whether in a model of HPV16 infection WRN levels were 254 reduced by HPV16. To do this we investigated WRN levels in oral keratinocytes that contain the HPV16 255 genome and support late stages of the viral life cycle (78). NOKs were derived from oral epithelium and 256 immortalized using telomerase (79) and we added the HPV16 genome to these cells and demonstrated a 257 host transcriptional reprogramming, an activation of the DDR, and the expression of several viral markers 258 demonstrating late stages of the viral life cycle in these cells (78). Western blots demonstrate that the 259 presence of HPV16 in the NOKs results in a decrease in WRN levels (Fig. 5c ); this was repeated and 260 quantitated (Fig. 5d ). This reduction was not due to a change in WRN RNA levels ( Fig. 5c ) and suggests 261 that the replication DDR signal generated by the entire HPV16 genome reduces WRN levels in oral 262 keratinocytes. 263 264
Functional interaction between SIRT1, WRN and E1 during E1-E2 mediated DNA replication. 265
The overexpression of SIRT1 in C33a cells does not alter E1-E2 DNA replication properties, although 266 removal of SIRT1 does boost this replication (41). The proposed mechanism of this increase in replication 267 is an increased acetylation and stabilization of the E2 protein that would enhance replication (41). C33a 268 already express a high level of SIRT1 and therefore, presumably, increasing the levels from exogenous 269 plasmids has no effect on the overall function of SIRT1 in E1-E2 replication. However, over expression of 270 WRN can repress E1-E2 DNA replication (Fig. 2b) . Both E1 and WRN can bind to DNA and both have 3' 271 to 5' helicase activity and we investigated whether E1 and WRN compete for the E1-E2 replicating DNA. 272
Such competition would result in elevation of E1 levels on the replicating DNA in the absence of WRN, 273 and would also explain why over expression of WRN represses E1-E2 replication. If this mechanism was 274 true, WRN repression of E1-E2 DNA replication should be reduced in the absence of SIRT1 due to the 275 failure of the acetylated WRN to bind to replicating DNA. This is indeed the case (Fig. 6a ). In wild type 276
C33a cells overexpression of WRN substantially represses E1-E2 replication (compare lane 2 with lane 1) 277 but in the absence or depletion of SIRT1 levels there is a reduction in this repression (compare lanes 4 and 278 6 with lane 2). This is reflective of a reduced recruitment of FLAG-WRN to E1-E2 replicating DNA in the 279 absence of WRN (Fig. 3e ). The results are presented relative to the levels in C33a wild type cells with the 280 E1-E2 replication complex equaling 1. Fig. S6a presents the control for these experiments. 281
If there is competition between E1 and WRN for the E1-E2 replicating DNA then we would expect elevated 282 levels of E1 on the DNA in the absence of WRN. To test this, we used our CRISPR/Cas9 WRN knock out 283 C33a cells. The results demonstrate that in the absence of WRN there is indeed an elevated level of E1 on 284 the replicating DNA (Figs. 6b) . The controls for these ChIP experiments are shown in Fig. S6b 
and S6c. 285
There is no change in the levels of the E1 and E2 proteins in the absence of WRN (Fig. 2c) , therefore there 286 is a difference in recruitment to the replicating DNA. This suggests that E1 and WRN are in competition 287
for replicating DNA and that in the absence of WRN the E1 protein has an enhanced ability to bind to the 288 replicating DNA. This would explain the increase in E1-E2 replication observed in the absence of WRN 289 ( Fig. 2b) . 290 291
Discussion 292
There is an intricate interaction between HPV and the DDR that promotes the viral life cycle (43-47, 49, 293 50), therefore efficient targeting of the HPV induced DDR offers therapeutic opportunities. Here we 294 demonstrate that lack of SIRT1 results in elevated and mutagenic E1-E2 DNA replication. Contributing to 295 this mutagenic replication is a failure to recruit WRN to the E1-E2 replicating DNA due to an enhanced 296 acetylation that prevents the interaction of WRN with the E1-E2 replicating DNA, even though there are 297 enhanced levels of WRN in the absence of SIRT1. Deletion of WRN from cells has an identical E1-E2 298 replication phenotype as deletion of SIRT1; elevated replication with an enhanced mutation frequency. The 299 elevation of replication in the absence of SIRT1 is likely due to an enhanced stability of E2 in the absence 300 of SIRT1 that is mediated by an elevated acetylation and stability of the E2 protein (41), while for WRN it 301 is likely related to the increased recruitment of the E1 replication factor to the replicating DNA in the 302 absence of WRN. There is no change in the levels of the viral proteins in the absence of WRN. Both E1 303 and WRN have 3' to 5' helicase activity (WRN also has a 3' to 5' exonuclease activity that contributes to 304 its DNA repair function) and therefore it is possible that both proteins compete for binding to the E1-E2 305 replicating DNA. 306
The results present the following model. Following infection, the E1-E2 proteins (along with the other E 307 viral proteins) are expressed and replication is initiated. This replication activates the DDR; E1 can do this 308 by itself and E1-E2 can do this together (48, (71) (72) (73) (74) . Notably, E1-E2 replication is not arrested in the 309 presence of an active DDR (48, 80) . At this early stage of the viral life cycle the virus has to increase its 310 genome copy number to around 20-50 genomes per cell therefore there is the potential for replication stress 311 on the viral genome during repeated initiation of replication resulting in replication fork clashes (52); this 312 replication stress and formation of aberrant DNA structures would activate the DDR. There is then the 313 recruitment of host HR factors to the viral genome and it is proposed that this recruitment results in HPV 314 employing an HR mechanism of DNA replication (51). HR would allow the virus to resolve these aberrant 315 DNA structures and clashing replication forks to enable successful amplification of the viral genome. The 316 activation of the DDR would then stimulate SIRT1 activity to deacetylate substrates that promote HR and 317 efficient repair of damaged DNA (38-40, 42, 53, 55, 59, 67, 81-84) . One of these substrates is WRN where 318 deacetylation promotes the interaction of WRN with damaged DNA (57, 58, 68) . This is precisely what we 319 observe with E1-E2 replicating DNA; in the absence of SIRT1 there are elevated levels of WRN acetylation 320 and this acetylated DNA has a reduced capacity for interaction with the replicating DNA promoting 321 mutagenic replication. It is known that the WRN protein is involved in promoting high fidelity replication 322 and has proposed roles in repairing stalled replication forks and contributing to the HR process, perhaps by 323 assisting with resection of double stranded DNA using its 3' to 5' exonuclease activity (61) (62) (63) (64) (85) (86) (87) (88) (89) (90) (91) . The 324 precise roles of the enzymatic activity of WRN in the DNA repair process is unclear and the E1-E2 325 replication system offers a unique opportunity to determine the contribution of these activities to the 326 maintenance of genomic integrity as complementation with wild type WRN restores the fidelity of E1-E2 327 replication in the WRN knock out cells. 328
Activation of the DDR stimulates WRN activity and subsequently levels decrease over a 12-hour period 329 following ATR phosphorylation; WRN is turned over via the proteasome (76). HPV replication stimulates 330 ATR activity (44, 92) and it is noticeable that in the presence of E1-E2 replication levels of WRN are 331 reduced. This reduction is partially reversed in the absence of SIRT1 as WRN is acetylated on lysine 332 residues that are also targeted for ubiquitination therefore elevated acetylation in the absence of SIRT1 333 protects WRN from degradation (57). This is precisely what we observe in our results; FLAG-WRN levels 334 are reduced in the presence of the E1-E2 replication complex but, in the absence of SIRT1, there are 335 elevated acetylation levels of WRN and an increased level of the protein. We demonstrate that in wild type 336 cells E1-E2 replication reduces the half-life of the WRN protein and this reduction is abrogated in the 337 absence of SIRT1. We also demonstrate that MG132 treatment can partially restore WRN levels in the 338 presence of the E1-E2 replication complex. Overall, the results suggest that E1-E2 activation of the DDR 339 promotes ATR phosphorylation of WRN to promote its degradation via the proteasome. However, it is clear 340 that not all of the WRN is degraded as WRN is important for promoting the fidelity of E1-E2 replication. 341
The virus seems to balance the levels of WRN; activation of the DDR targets the protein for degradation 342 via the proteasome and this requires SIRT1 deacetylation. However, it retains an active level of WRN that 343 promotes the fidelity of replication as a total absence of WRN results in mutagenic replication. 344
What does this mean for the viral life cycle? It is clear that high risk HPV (HR-HPV) containing 345 keratinocytes have an active DDR but yet can still undergo a cell cycle (46, 78) , therefore the DDR is 346 different from that stimulated by an external DNA damaging agent that would promote cell cycle arrest and 347 promotion of DNA damage repair followed by a restart of DNA replication and reentry into the cell cycle. 348
It remains to be fully elucidated how virally infected cells retain an ability to have an active DDR and an 349 ongoing cell cycle. As WRN is crucial to replication fork arrest and repair of DNA it is possible that the 350 reduced levels of WRN stimulated by E1-E2 (that is also observed in our oral keratinocyte model of What does this mean for therapeutic approaches to HPV diseases? Recently it has been demonstrated that 358 the majority of HPV16 positive head and neck cancers retain an episomal viral genome replicating in an 359 E1-E2 dependent manner (93-96) therefore direct targeting of HPV replication offers therapeutic 360
opportunities. Currently we are investigating pathway manipulation (including the DDR) that could 361 stabilize the WRN protein in HR-HPV positive cells; such elevation would block E1-E2 replication. This 362 would reduce the viral genome copy number in cancer cells and could contribute to therapeutic targeting 363 of HPV positive cancers with episomal viral genomes. In addition, cells that lack WRN have an increased 364 sensitivity to certain DNA damaging drugs including camptothecin. It would be interesting to test the 365 difference in response of HPV16 positive and negative cancers to this drug and we are currently developing 366 PDX models for this purpose. 367
Overall the results demonstrate that SIRT1 and WRN contribute to E1-E2 replication control and fidelity, 368 and that they likely act in a coordinated fashion. Future studies will focus on gaining further insights into 369 the mechanisms that these proteins use to regulate E1-E2 replication and HR-HPV life cycles with a view 370 to determining novel ways to target viral replication for therapeutic gain. One final comment is that this 371 down regulation of WRN would also result in an increased vulnerability for the host genome to 372 mutagenesis, therefore this is also a novel mechanism that could contribute to HR-HPV oncogenesis. 373 374 375
Materials and Methods 376
Cell line, plasmids and reagents. C33a cells (Cat# HTB-31) were obtained from ATCC (American Type 377
Culture Collection) and were grown in Dulbecco Modified Eagle Medium (DMEM) with 10% fetal bovine 378 serum (FBS) in a humidified CO2 incubator in 5% CO2 at 37 °C. C33a SIRT1 depleted cells have been 379 described previously (41). HPV16-E2 (97), hemagglutinin-E1 (HA-E1) (72), pOri (69) and pOri-Lacz (66) 380 plasmids have been described previously. For WRN knockout CRISPR, WRN Double Nickase Plasmid (h) 381
(Cat # sc-401860-NIC) was purchased from Santa Cruz. C33a WRN-/-Clone1 and Clone 2 were generated 382 as described for the SIRT1 knock out cells (41). Double Nickase plasmid consists of a pair of plasmids each 383 encoding a D10A mutated Cas9 nuclease and a target specific 20nt guide RNA designed to knockout 384 particular gene expression with greater specificity than a single CRISPR/Cas9 KO counterpart. FLAG-WT-385 SIRT1 (Cat # 1791), FLAG-MT-SIRT1 (H363Y) (Cat# 1792) and MYC-WT-WRN (Cat# pMM290) 386 plasmid were purchased from Addgene. The Flag-WRN expression plasmid has been described previously 387 (91). Cycloheximide (Cat # 97064-724) was purchased from VWR (USA). MG132 (Cat# C2211-5MG) 388 was purchased from Sigma (USA). 389
Western Blot. Cells were harvested and proteins extracted with lysis buffer (0.5% Nonidet P-40 , 390 50 mM Tris, pH 7.8, 150 mM NaCl with protease inhibitor cocktail and phosphatase inhibitor) and western 391 blots carried out as described (41). ~50 µg of protein was run on 4 to 12% gradient gel after which it was 392 transferred onto a nitrocellulose membrane. The membrane was blocked with Odyssey blocking buffer and 393 then incubated with respective primary antibodies. Imaging was done using the Odyssey Li-Cor imaging 394 system. The images were quantified via Image Studio Lite Version 5.2 software and represented as 395
histogram. 396
Chromatin immunoprecipitation (ChIP). Cells after plating at a density of 5 x 10 5 were transfected with 397 1 μg each of pOri, E1 and E2 plasmid using the CaPO4 precipitation method. 48 h post transfection the 398 cells were harvested by scraping and processed for chromatin as described previously (41). Chromatin 399 concentration was determined by NanoDrop spectrophotometer. ~100 µg of chromatin from each sample 400 was used for experiment. A/G magnetic beads were used to pull down the antibody-chromatin complex. To 401
show antibody specificity each of the samples were pulled down with rabbit isotype control shown in the 402 supplementary figures. The immunoprecipitated chromatin was processed for qPCR and a pOri primer used 403 to measure the levels of immunoprecipitation of the chromatin. 404
Replication Assay. Cells were plated in a 100 mm 2 tissue culture disc and transfected with 10 ng pOri, 1µg 405 E1 and 10 ng E2 plasmids using the CaPO4 precipitation (41). 48 h post transfection, the cells were washed 406 with 1x PBS and then harvested using Hirt solution ( 10mM EDTA, 0.5% SDS) and the samples were 407 processed for quantitative PCR (qPCR) as described previously (69). 408 DNA Mutagenesis analysis. DNA was harvested as described for the replication assay and the samples 409 digested with DPNI to remove the input DNA and then extracted with phenol:chloroform:isoamyl alcohol 410 (25:24:1). DNA was precipitated with ethanol and was re-suspended in 150 µL of 10% glycerol. 75 µL of 411 the DNA were electroporated into DH10B bacteria and plated on 100 µg/mL X-gal Lysogeny Broth (LB) 412 agar with Kanamycin selection (66). 413 Immunoprecipitation (IP). 200 μg of protein lysate from each sample was used for pull down and the 414 volume was made up to 300µl using lysis buffer. 2µg of antibody was used for the pull down as described 415 (41). The following day, protein A-Sepharose bead slurry was added to each sample and incubated on a 416 rotor at 4°C for 5 h. The protein: beads mixture was then washed and processed for western blotting (41). 417
Cycloheximide time chase (CHX). 48 h post transfection 100 µg/ml CHX containing medium was added 418 to each plate for the specified time points. After incubation the cells were harvested and processed for 419 western blotting. 420
Proteasomal degradation. The cells were pretreated with 10µg of MG132 for 18 h before harvesting and 421 processing for western blots. 422 RNA assay. The SV total RNA isolation system kit (Promega) was used to isolate RNA from cells. High-423
Capacity cDNA Reverse Transcription Kit from Invitrogen was used to synthesize cDNA which was 424 processed for quantitative PCR (qPCR) . 425
Statistical analysis. A two-tailed student's t-test was employed where *P < 0.05 and ^P<0.05 was 426 considered to be statistically significant. experiments. C) The extracts shown in A were immunoprecipitated by FLAG and western blotted for the 757 indicated proteins. FLAG-WRN interacts with E1 (lanes 3, 5 and 6) but not with E2 (lane 4, 5 and 6). 758
Lane 7 is a control immunoprecipitation carried out with rabbit serum and no immunoprecipitation of the 759 viral factors is observed. D) FLAG-WRN was transfected into C33a wild type cells and cycloheximide 760 added for the indicated time period prior to cell harvesting and western blotting on protein extracts. E) 761 FLAG-WRN was transfected into C33a SIRT1 -/-Clone 1 cells and cycloheximide added for the 762 indicated time period prior to cell harvesting and western blotting on protein extracts. F) FLAG-WRN 763 was transfected along with pOri (a plasmid containing the HPV16 origin of replication) and E1 and E2 764 expression plasmids into C33a wild type cells and cycloheximide added for the indicated time period 765 prior to cell harvesting and western blotting on protein extracts. G) FLAG-WRN was transfected along 766 with pOri (a plasmid containing the HPV16 origin of replication) and E1 and E2 expression plasmids into 767
C33a SIRT1 -/-Clone 1 cells and cycloheximide added for the indicated time period prior to cell 768 harvesting and western blotting on protein extracts 769 repeated three times and the results quantitated and graphed on a histogram. There is a significant 775 increase * in FLAG-WRN in the presence of MG132 when the E1-E2 replication complex is present, p-776 value less than 0.05, standard error bars are shown. C) NOKs and NOKs+HPV16 (cells that contain 777 episomal HPV16 genomes and support late stages of the viral life cycle (78)) were blotted for endogenous 778 WRN protein levels. D) Duplicate experiments of that shown in A were quantitated and there is a 779 significant decrease in WRN protein levels in the presence of HPV16, p-value less than 0.05, standard 780 error bars shown. E) This reduction is not due to a reduction in WRN RNA levels, an average of three 781 independent experiments is shown from reverse-transcriptase quantitative PCR and there is no significant 782 difference in WRN RNA in the absence or presence of HPV16, standard error bars are shown. 783 
